Indicated for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xBUd6No
No comments:
Post a Comment